Literature DB >> 18556237

Activation of the mammalian target of rapamycin complex 1 is both necessary and sufficient to stimulate eukaryotic initiation factor 2Bvarepsilon mRNA translation and protein synthesis.

Neil Kubica1, Jamie L Crispino, James W Gallagher, Scot R Kimball, Leonard S Jefferson.   

Abstract

In a previous study we demonstrated a requirement for activation of mTORC1 in the stimulation of eIF2Bepsilon mRNA translation in skeletal muscle in response to resistance exercise. Although that study established the necessity of mTORC1 activation, the experimental model used did not lend itself readily to address the question of whether or not mTORC1 activation was sufficient to produce the response. Therefore, the present study was designed to address the sufficiency of mTORC1 activation, using cultures of Rat2 fibroblasts in which mTORC1 signaling was repressed by serum/leucine-depletion and stimulated by repletion of leucine and/or IGF-1. Repletion with leucine and IGF-1 caused a shift of eIF2Bepsilon mRNA into actively translating polysomes and a stimulation of new eIF2Bepsilon protein synthesis, but had no effect on mRNAs encoding the other four eIF2B subunits. Stimulation of eIF2Bepsilon translation was reversed by pre-treatment with the mTORC1 inhibitor rapamycin. Exogenous overexpression of FLAG-Rheb, a proximal activator of mTORC1, also caused a re-distribution of eIF2Bepsilon mRNA into polysomes and a stimulation of eIF2Bepsilon protein synthesis. The stimulation of eIF2Bepsilon mRNA translation occurred in the absence of any effect on eIF2Bepsilon mRNA abundance. RNAi-mediated knockdown of eIF2Bepsilon resulted in reduced cellular proliferation, a result that phenocopied the known cytostatic effect of mTORC1 repression. Overall the results demonstrate that activation of mTORC1 is both necessary and sufficient to stimulate eIF2Bepsilon mRNA translation and that this response may represent a novel mechanism through which mTORC1 can affect mRNA translation initiation, rates of protein synthesis, and cellular growth/proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556237      PMCID: PMC2601645          DOI: 10.1016/j.biocel.2008.04.010

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  50 in total

1.  Intracellular signaling specificity in skeletal muscle in response to different modes of exercise.

Authors:  G A Nader; K A Esser
Journal:  J Appl Physiol (1985)       Date:  2001-05

2.  Time course evaluation of protein synthesis and glucose uptake after acute resistance exercise in rats.

Authors:  J M Hernandez; M J Fedele; P A Farrell
Journal:  J Appl Physiol (1985)       Date:  2000-03

3.  Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway.

Authors:  J C Anthony; F Yoshizawa; T G Anthony; T C Vary; L S Jefferson; S R Kimball
Journal:  J Nutr       Date:  2000-10       Impact factor: 4.798

4.  Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin.

Authors:  Andrew R Tee; Rana Anjum; John Blenis
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

5.  Immediate response of mammalian target of rapamycin (mTOR)-mediated signalling following acute resistance exercise in rat skeletal muscle.

Authors:  Douglas R Bolster; Neil Kubica; Stephen J Crozier; David L Williamson; Peter A Farrell; Scot R Kimball; Leonard S Jefferson
Journal:  J Physiol       Date:  2003-08-22       Impact factor: 5.182

6.  mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.

Authors:  Diane C Fingar; Celeste J Richardson; Andrew R Tee; Lynn Cheatham; Christina Tsou; John Blenis
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  Differential activation of mTOR signaling by contractile activity in skeletal muscle.

Authors:  Jascha D Parkington; Adam P Siebert; Nathan K LeBrasseur; Roger A Fielding
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-07-24       Impact factor: 3.619

8.  Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.

Authors:  Claudine Lassarre; Jean-Marc Ricort
Journal:  Endocrinology       Date:  2003-07-24       Impact factor: 4.736

9.  The chemotactic and mitogenic responses of vascular smooth muscle cells to insulin-like growth factor-I require the activation of ERK1/2.

Authors:  Cunming Duan
Journal:  Mol Cell Endocrinol       Date:  2003-08-29       Impact factor: 4.102

10.  The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase.

Authors:  Tawhid Ahmad; Gillian Farnie; Nigel J Bundred; Neil G Anderson
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

View more
  13 in total

Review 1.  Control of translation initiation through integration of signals generated by hormones, nutrients, and exercise.

Authors:  Scot R Kimball; Leonard S Jefferson
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

2.  ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling.

Authors:  Jeremiah N Winter; Leonard S Jefferson; Scot R Kimball
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

3.  Simvastatin represses protein synthesis in the muscle-derived C₂C₁₂ cell line with a concomitant reduction in eukaryotic initiation factor 2B expression.

Authors:  Alexander P Tuckow; Sarah J Jefferson; Scot R Kimball; Leonard S Jefferson
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-01-11       Impact factor: 4.310

4.  Eukaryotic initiation factor 2B epsilon induces cap-dependent translation and skeletal muscle hypertrophy.

Authors:  David L Mayhew; Troy A Hornberger; Hannah C Lincoln; Marcas M Bamman
Journal:  J Physiol       Date:  2011-04-11       Impact factor: 5.182

5.  Glucagon-Dependent Suppression of mTORC1 is Associated with Upregulation of Hepatic FGF21 mRNA Translation.

Authors:  Jaclyn E Welles; Michael D Dennis; Leonard S Jefferson; Scot R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-18       Impact factor: 4.310

Review 6.  Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass.

Authors:  Craig A Goodman; David L Mayhew; Troy A Hornberger
Journal:  Cell Signal       Date:  2011-07-23       Impact factor: 4.315

7.  Identification of ubiquitin-modified lysine residues and novel phosphorylation sites on eukaryotic initiation factor 2B epsilon.

Authors:  Alexander P Tuckow; Abid A Kazi; Scot R Kimball; Leonard S Jefferson
Journal:  Biochem Biophys Res Commun       Date:  2013-05-21       Impact factor: 3.575

8.  Chronic high fat feeding attenuates load-induced hypertrophy in mice.

Authors:  Mitchell Sitnick; Sue C Bodine; John C Rutledge
Journal:  J Physiol       Date:  2009-10-12       Impact factor: 5.182

9.  Effects of chronic overload on muscle hypertrophy and mTOR signaling in young adult and aged rats.

Authors:  Angela Chalé-Rush; Evan P Morris; Tracee L Kendall; Naomi E Brooks; Roger A Fielding
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-10-06       Impact factor: 6.053

10.  Muscle hypertrophy is associated with increases in proteasome activity that is independent of MuRF1 and MAFbx expression.

Authors:  Leslie M Baehr; Matthew Tunzi; Sue C Bodine
Journal:  Front Physiol       Date:  2014-02-21       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.